Could Weight-Based Immunotherapy Dosing Improve Outcomes for Some?

(MedPage Today) -- Patients with cancer who were overweight or obese appeared to have better outcomes when they underwent immune checkpoint inhibitor (ICI) therapy administered with a weight-based dosing strategy, according to a single-center study...